“There’s no better place to meet our industry partners in person and get a first-hand feel for the state of the pharma industry than at CPHI,” says Borderless Partner Rosalie Harrison, who leads the firm’s life sciences practice. The event in Milan is a unique opportunity to meet our network of business partners, clients, and executives and catch up on the latest developments in the sector.
“I am looking forward to being present at CPHI on October 8 and 9. I hope to meet you if you are attending. Let’s plan a moment to share a coffee using this link.”
“See you in Milan!”
Rosalie can be reached at rosalie.harrison@borderless.net and +32 470 993061.
In a press release Thursday, UCB revealed a plan to establish a “new, state-of-the-art biologics manufacturing facility in the United States.” The company hasn’t settled on the exact location, but it says the site will create 300 high-skilled jobs once complete.
Schott Pharma has expanded its Lukácsháza site with a new facility for prefillable glass syringes, which are used for GLP-1 therapies, vaccines, and biologics. Since opening in June 2024, the site has added 120 employees, begun production, and increased capacity.
LinkedIn Twitter Xing EmailThis year marked a significant milestone for the nutraceutical industry as Vitafoods Europe made its highly anticipated move from Geneva to Barcelona, drawing a record-breaking 25,500+ attendees […]
